Eprotirome with statin therapy

Eprotirome with statin therapy: "Eprotirome further reduces cholesterol levels in statin-treated patients
March 10, 2010
Download slides
Baltimore, MD - Adding the investigational thyroid hormone analog eprotirome (Karo Bio) to statin therapy in patients with dyslipidemia results in substantially further reductions in LDL cholesterol and other lipid and lipoprotein levels, a new study shows [1]. The improvements in the atherogenic profile occurred without adversely affecting the heart or skeletal system, two common side effects of thyroid hormone analogs, report investigators."